Variant report
Variant | rs1921079 |
---|---|
Chromosome Location | chr12:66505299-66505300 |
allele | C/T |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:66501200-66505400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr12:66501200-66516000 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
3 | chr12:66501400-66514600 | Weak transcription | A549 | lung |
4 | chr12:66501400-66515400 | Weak transcription | Liver | Liver |
5 | chr12:66501600-66505400 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
6 | chr12:66501600-66512200 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
7 | chr12:66501600-66513000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr12:66501600-66513200 | Weak transcription | Brain Anterior Caudate | brain |
9 | chr12:66501600-66513200 | Weak transcription | HSMM | muscle |
10 | chr12:66501600-66513600 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
11 | chr12:66501600-66513800 | Weak transcription | Adipose Nuclei | Adipose |
12 | chr12:66501600-66514600 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
13 | chr12:66501600-66514600 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
14 | chr12:66501600-66514600 | Weak transcription | Rectal Mucosa Donor 29 | rectum |
15 | chr12:66501600-66516000 | Weak transcription | Brain Hippocampus Middle | brain |
16 | chr12:66501600-66517600 | Weak transcription | Right Ventricle | heart |
17 | chr12:66501800-66512400 | Weak transcription | Primary monocytes fromperipheralblood | blood |
18 | chr12:66501800-66516800 | Weak transcription | NHEK | skin |
19 | chr12:66502000-66508800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
20 | chr12:66502000-66513400 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
21 | chr12:66502000-66518000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
22 | chr12:66502400-66515800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
23 | chr12:66502400-66516000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
24 | chr12:66502400-66518400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
25 | chr12:66502600-66505600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
26 | chr12:66502600-66516000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
27 | chr12:66502600-66516200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
28 | chr12:66505200-66505400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
29 | chr12:66505200-66505600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
30 | chr12:66505200-66505800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
31 | chr12:66505200-66505800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
32 | chr12:66505200-66505800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
33 | chr12:66505200-66505800 | Enhancers | NHDF-Ad | bronchial |